| Literature DB >> 23717577 |
Chris Bath1, Danson Muttuvelu, Jeppe Emmersen, Henrik Vorum, Jesper Hjortdal, Vladimir Zachar.
Abstract
Corneal epithelium is maintained throughout life by well-orchestrated proliferation of limbal epithelial stem cells (LESCs), followed by migration and maturation centripetally towards the ocular surface. Disturbance of LESCs can potentially lead to a blinding condition, which can be reversed by reconstitution of a functional LESC pool. The current clinical procedures are effective to some degree, however, deeper knowledge of the molecular interplay within the limbal niche is necessary to achieve a fully satisfactory patient outcome. The present study was thus undertaken to carry out a comprehensive transcriptome analysis of four distinct human limbal compartments, including basal limbal crypts (BLCs), superficial limbal crypts (SLCs), cornea, and the supporting stroma, with the aid of laser capture microdissection and deep RNA sequencing. The tissue harvest pipeline was rigorously optimized so that the exposure to cold ischemia would be less than five minutes. The global gene ontology analysis confirmed existence of primitive cells in BLCs, migratory and activated cells in SLCs, and differentiated cells in cornea. Interestingly, many significantly upregulated genes in SLCs mapped to processes involved in regulation of vasculature, such as sFLT1. In contrast, BLCs exhibited many genes mapping to neurogenic processes and processes related to cell development. The primitive nature of BLCs was, furthermore, confirmed by the KEGG pathway analysis, and some potential regulators of LESCs were revealed, such as Lrig1 and SOX9. The analysis also yielded comprehensive lists of uniquely expressed genes in both BLCs and cornea, which may be useful to identify possible biomarkers. In conclusion, the current investigation provides new insight into the relationship between distinct cell populations within the limbal niche, identifies candidates to be verified for novel biological functions, and yields a wealth of information for prospective data mining.Entities:
Mesh:
Year: 2013 PMID: 23717577 PMCID: PMC3661480 DOI: 10.1371/journal.pone.0064244
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1LCM of the corneal limbus and comparison of the compartment-specific libraries.
(A) Representative images from the LCM procedure and the electropherogram of the isolated RNA. Scale bars high power magnification, 200 µm; low power magnification, 1 mm. (B) Principal component analysis and volcano plots of the compartment-specific libraries. (C) Distribution of transcriptional expression between limbal compartments using four-way Venn Diagrams.
Figure 2Heatmap of significantly expressed genes in BLCs, SLCs, cornea, and stroma after hierarchical clustering based on RPKM values.
Red indicates high, and blue low RPKM. High resolution inserts for FHDC1 and BTBD6, and ATPB1 and NBL1 are presented.
Figure 3Gene ontology analysis of significantly upregulated genes in BLCs.
(A) Network of significantly enriched terms. (B) Bar chart of significantly enriched terms. Numbers next to the bars indicate total number of genes mapping to the specific term.
Figure 4Gene ontology analysis of significantly upregulated genes in SLCs.
(A) Network of significantly enriched terms. (B) Bar chart of significantly enriched terms. Numbers next to the bars indicate total number of genes mapping to the specific term.
Figure 5Comparative gene ontology analysis of significantly enriched terms between BLCs and SLCs.
(A) Network of significantly enriched terms. (B) Bar chart of significantly enriched terms. The stippled line indicates gene equilibrium.
Figure 6Gene ontology analysis of significantly upregulated genes in cornea.
(A) Network of significantly enriched terms. (B) Bar chart of significantly enriched terms. Numbers next to the bars indicate total number of genes mapping to the specific term.
Figure 7Gene ontology analysis of significantly upregulated genes in stroma.
(A) Network of significantly enriched terms. (B) Bar chart of significantly enriched terms. Numbers next to the bars indicate total number of genes mapping to the specific term.
Top 50 candidate LESC markers .
| Ensemble ID | Gene Symbol | Description | FDR p-value | RPKM |
| ENSG00000143153 | ATP1B1 | ATPase, Na+/K+ transporting, beta 1 polypeptide | 0.000449 | 10.25 |
| ENSG00000158747 | NBL1 | neuroblastoma, suppression of tumorigenicity 1 | 2.75E-12 | 5.25 |
| ENSG00000144057 | ST6GAL2 | ST6 beta-galactosamide alpha-2,6-sialyltranferase 2 | 0 | 3.33 |
| ENSG00000111850 | C6orf162 | chromosome 6 open reading frame 162 | 0.000013 | 2.26 |
| ENSG00000135960 | EDAR | ectodysplasin A receptor | 6.68E-14 | 2.21 |
| ENSG00000113396 | SLC27A6 | solute carrier family 27 (fatty acid transporter), member 6 | 0 | 2.12 |
| ENSG00000101191 | DIDO1 | death inducer-obliterator 1 | 0.03 | 2.07 |
| ENSG00000256673 | RP11-599J14.2 | Known pseudogene | 0.000415 | 1.94 |
| ENSG00000183495 | EP400 | E1A binding protein p400 | 2.37E-09 | 1.66 |
| ENSG00000263050 | RP11-667K14.3 | Novel lincRNA | 0.000264 | 1.6 |
| ENSG00000249742 | RP11-217E13.1 | Putative lincRNA | 0.000264 | 1.49 |
| ENSG00000143228 | NUF2 | NUF2, NDC80 kinetochore complex component, homolog (S. cerevisiae) | 0.00000145 | 1.44 |
| ENSG00000163067 | ZNF2 | zinc finger protein 2 | 4.14E-08 | 1.42 |
| ENSG00000129810 | SGOL1 | shugoshin-like 1 (S. pombe) | 0.00959 | 1.23 |
| ENSG00000114790 | ARHGEF26 | Rho guanine nucleotide exchange factor (GEF) 26 | 0.000041 | 1.16 |
| ENSG00000185760 | KCNQ5 | potassium voltage-gated channel, KQT-like subfamily, member 5 | 6.91E-12 | 1.15 |
| ENSG00000259483 | RP11-930O11.2 | Novel processed transcript | 0.02 | 1.03 |
| ENSG00000254754 | RP11-20J1.1 | Putative lincRNA | 0.03 | 0.91 |
| ENSG00000093009 | CDC45 | cell division cycle 45 homolog (S. cerevisiae) | 0.000084 | 0.89 |
| ENSG00000169372 | CRADD | CASP2 and RIPK1 domain containing adaptor with death domain | 0.0021 | 0.85 |
| ENSG00000260128 | ULK4P2 | unc-51-like kinase 4 (C. elegans) pseudogene 2 | 6.69E-08 | 0.84 |
| ENSG00000158301 | GPRASP2 | G protein-coupled receptor associated sorting protein 2 | 0.02 | 0.82 |
| ENSG00000171126 | KCNG3 | potassium voltage-gated channel, subfamily G, member 3 | 6.12E-12 | 0.81 |
| ENSG00000254744 | CTD-3076O17.1 | Novel antisense | 0.00553 | 0.8 |
| ENSG00000250673 | RP11-6L6.2 | Putative protein coding | 0.03 | 0.8 |
| ENSG00000196526 | AFAP1 | actin filament associated protein 1 | 3.01E-08 | 0.79 |
| ENSG00000151617 | EDNRA | endothelin receptor type A | 0.000825 | 0.76 |
| ENSG00000125257 | ABCC4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 | 2.68E-09 | 0.72 |
| ENSG00000130669 | PAK4 | p21 protein (Cdc42/Rac)-activated kinase 4 | 0.00222 | 0.72 |
| ENSG00000177098 | SCN4B | sodium channel, voltage-gated, type IV, beta subunit | 0.0000106 | 0.72 |
| ENSG00000106665 | CLIP2 | CAP-GLY domain containing linker protein 2 | 0.02 | 0.71 |
| ENSG00000112530 | PACRG | PARK2 co-regulated | 0.04 | 0.7 |
| ENSG00000174827 | PDZK1 | PDZ domain containing 1 | 0.0000244 | 0.69 |
| ENSG00000140093 | SERPINA10 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 | 0.00125 | 0.69 |
| ENSG00000123473 | STIL | SCL/TAL1 interrupting locus | 0.000000555 | 0.69 |
| ENSG00000102858 | MGRN1 | mahogunin ring finger 1, E3 ubiquitin protein ligase | 0.00111 | 0.67 |
| ENSG00000186715 | MST1P9 | macrophage stimulating 1 (hepatocyte growth factor-like) pseudogene 9 | 0.000000182 | 0.61 |
| ENSG00000261777 | RP11-529K1.2 | Novel processed transcript | 0.0000735 | 0.61 |
| ENSG00000134253 | TRIM45 | tripartite motif containing 45 | 0.03 | 0.61 |
| ENSG00000203872 | C6orf163 | chromosome 6 open reading frame 163 | 0.0092 | 0.59 |
| ENSG00000255263 | RP11-718B12.3 | Putative antisense | 0.00359 | 0.57 |
| ENSG00000225377 | RP5-1103G7.4 | Novel antisense | 0.01 | 0.57 |
| ENSG00000215760 | TAF9BP2 | TAF9B RNA polymerase II, TATA box binding protein (TBP)-associated factor, 31 kDa pseudogene 2 | 0.05 | 0.57 |
| ENSG00000158813 | EDA | ectodysplasin A | 0.00105 | 0.56 |
| ENSG00000248125 | CTB-73N10.1 | Novel lincRNA | 0.000974 | 0.55 |
| ENSG00000236215 | RP11-262H14.10 | Known pseudogene | 0.05 | 0.55 |
| ENSG00000235167 | RP11-425M5.5 | Putative processed transcript | 0.00854 | 0.54 |
| ENSG00000095627 | TDRD1 | tudor domain containing 1 | 4.03E-11 | 0.54 |
| ENSG00000125319 | C17orf53 | chromosome 17 open reading frame 53 | 0.02 | 0.52 |
| ENSG00000253983 | RP1-16A9.1 | Novel antisense | 0.02 | 0.51 |
Genes with uniquely identified transcript in BLCs, q-value <0.05, and higher RPKM values than SLCs.
Top 50 candidate differentiation markers .
| Ensemble ID | Gene Symbol | Description | FDR p-value | RPKM |
| ENSG00000137460 | FHDC1 | FH2 domain containing 1 | 1.99E-14 | 3.83 |
| ENSG00000184887 | BTBD6 | BTB (POZ) domain containing 6 | 3.85E-07 | 3.56 |
| ENSG00000071051 | NCK2 | NCK adaptor protein 2 | 1.60E-09 | 2.94 |
| ENSG00000165730 | STOX1 | storkhead box 1 | 1.14E-03 | 2.26 |
| ENSG00000169379 | ARL13B | ADP-ribosylation factor-like 13B | 0 | 2.12 |
| ENSG00000125898 | FAM110A | family with sequence similarity 110, member A | 2.15E-09 | 2.04 |
| ENSG00000229109 | RP11-439K3.1 | Putative antisense | 8.69E-05 | 1.91 |
| ENSG00000228470 | RP11-176D17.3 | Novel processed transcript | 0.02 | 1.88 |
| ENSG00000249955 | RP11-6E9.4 | Novel antisense | 1.19E-03 | 1.82 |
| ENSG00000162076 | FLYWCH2 | FLYWCH family member 2 | 0.04 | 1.66 |
| ENSG00000263041 | RP11-355F22.1 | Known processed transcript | 2.94E-05 | 1.49 |
| ENSG00000198945 | L3MBTL3 | l(3)mbt-like 3 (Drosophila) | 7.78E-09 | 1.46 |
| ENSG00000257542 | OR7E5P | olfactory receptor, family 7, subfamily E, member 5 pseudogene | 1.04E-04 | 1.46 |
| ENSG00000224616 | RP11-305E17.6 | Novel antisense | 5.43E-03 | 1.41 |
| ENSG00000173610 | UGT2A1 | UDP glucuronosyltransferase 2 family, polypeptide A1, complex locus | 0 | 1.29 |
| ENSG00000145864 | GABRB2 | gamma-aminobutyric acid (GABA) A receptor, beta 2 | 0 | 1.18 |
| ENSG00000148300 | REXO4 | REX4, RNA exonuclease 4 homolog (S. cerevisiae) | 2.93E-04 | 1.14 |
| ENSG00000236624 | CCDC163P | coiled-coil domain containing 163, pseudogene | 4.52E-07 | 0.96 |
| ENSG00000260548 | RP6-24A23.6 | Putative protein coding | 3.27E-03 | 0.95 |
| ENSG00000185437 | SH3BGR | SH3 domain binding glutamic acid-rich protein | 2.05E-03 | 0.95 |
| ENSG00000120217 | CD274 | CD274 molecule | 5.17E-12 | 0.93 |
| ENSG00000089041 | P2RX7 | purinergic receptor P2X, ligand-gated ion channel, 7 | 1.57E-06 | 0.9 |
| ENSG00000171428 | NAT1 | N-acetyltransferase 1 (arylamine N-acetyltransferase) | 0.02 | 0.87 |
| ENSG00000138669 | PRKG2 | protein kinase, cGMP-dependent, type II | 1.03E-14 | 0.75 |
| ENSG00000239388 | ASB14 | ankyrin repeat and SOCS box containing 14 | 5.90E-05 | 0.73 |
| ENSG00000254731 | CTD-2005H7.1 | Novel lincRNA | 0.04 | 0.73 |
| ENSG00000134256 | CD101 | CD101 molecule | 4.96E-03 | 0.68 |
| ENSG00000260281 | RP11-329J18.2 | Novel antisense | 0.01 | 0.65 |
| ENSG00000197093 | GAL3ST4 | galactose-3-O-sulfotransferase 4 | 1.26E-07 | 0.62 |
| ENSG00000066185 | ZMYND12 | zinc finger, MYND-type containing 12 | 1.24E-03 | 0.6 |
| ENSG00000236123 | CEACAMP11 | carcinoembryonic antigen-related cell adhesion molecule pseudogene 11 | 0.03 | 0.59 |
| ENSG00000050030 | KIAA2022 | Known protein coding | 5.67E-06 | 0.59 |
| ENSG00000255647 | AC093510.1 | Known pseudogene | 0.03 | 0.52 |
| ENSG00000253549 | RP11-317J10.2 | Novel antisense | 1.59E-03 | 0.48 |
| ENSG00000248371 | CTC-347C20.2 | Putative lincRNA | 0.02 | 0.46 |
| ENSG00000166321 | NUDT13 | nudix (nucleoside diphosphate linked moiety X)-type motif 13 | 0.05 | 0.46 |
| ENSG00000233639 | AC018730.1 | Novel antisense | 0.02 | 0.45 |
| ENSG00000188820 | FAM26F | family with sequence similarity 26, member F | 3.27E-03 | 0.45 |
| ENSG00000236409 | NRADDP | neurotrophin receptor associated death domain, pseudogene | 0.04 | 0.45 |
| ENSG00000141028 | CDRT15P1 | CMT1A duplicated region transcript 15 pseudogene 1 | 0.03 | 0.44 |
| ENSG00000251584 | RP11-440I14.3 | Putative lincRNA | 0.03 | 0.44 |
| ENSG00000257052 | RP11-881M11.2 | Novel antisense | 0.03 | 0.43 |
| ENSG00000183423 | LRIT3 | leucine-rich repeat, immunoglobulin-like and transmembrane domains 3 | 2.92E-04 | 0.41 |
| ENSG00000152208 | GRID2 | glutamate receptor, ionotropic, delta 2 | 5.36E-14 | 0.4 |
| ENSG00000253479 | RP11-744J10.3 | Novel lincRNA | 0.05 | 0.4 |
| ENSG00000182814 | FUNDC2P2 | FUN14 domain containing 2 pseudogene 2 | 6.79E-03 | 0.39 |
| ENSG00000137766 | UNC13C | unc-13 homolog C (C. elegans) | 6.24E-14 | 0.39 |
| ENSG00000184374 | COLEC10 | collectin sub-family member 10 (C-type lectin) | 3.80E-03 | 0.38 |
| ENSG00000165807 | PPP1R36 | protein phosphatase 1, regulatory subunit 36 | 1.19E-05 | 0.37 |
| ENSG00000203871 | C6orf164 | Known protein coding | 0.02 | 0.36 |
Genes with uniquely identified transcripts in cornea, q-value <0.05, and higher RPKM values than SLCs.